Cargando…

Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation

INTRODUCTION: The prevalence of coronary artery disease (CAD) detected in preoperative work-up for transcatheter aortic valve implantation (TAVI) is high. Instead, the management of a concomitant CAD remains unclear. We evaluate the impact of CAD and percutaneous coronary intervention (PCI) on TAVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Matta, Anthony G., Lhermusier, Thibault, Parada, Francisco Campelo, Bouisset, Frederic, Canitrot, Ronan, Nader, Vanessa, Blanco, Stéphanie, Elbaz, Meyer, Roncalli, Jerome, Carrié, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016584/
https://www.ncbi.nlm.nih.gov/pubmed/33824628
http://dx.doi.org/10.1155/2021/6672400
_version_ 1783673889436467200
author Matta, Anthony G.
Lhermusier, Thibault
Parada, Francisco Campelo
Bouisset, Frederic
Canitrot, Ronan
Nader, Vanessa
Blanco, Stéphanie
Elbaz, Meyer
Roncalli, Jerome
Carrié, Didier
author_facet Matta, Anthony G.
Lhermusier, Thibault
Parada, Francisco Campelo
Bouisset, Frederic
Canitrot, Ronan
Nader, Vanessa
Blanco, Stéphanie
Elbaz, Meyer
Roncalli, Jerome
Carrié, Didier
author_sort Matta, Anthony G.
collection PubMed
description INTRODUCTION: The prevalence of coronary artery disease (CAD) detected in preoperative work-up for transcatheter aortic valve implantation (TAVI) is high. Instead, the management of a concomitant CAD remains unclear. We evaluate the impact of CAD and percutaneous coronary intervention (PCI) on TAVI procedures. MATERIALS AND METHODS: A retrospective study was conducted on 1336 consecutive patients who underwent TAVI in Toulouse University Hospital, Rangueil, France. The studied population was divided into 2 groups: CAD-TAVI group and No CAD-TAVI group. Then, the CAD-TAVI group was segregated into 2 subgroups: PCI-TAVI group and No PCI-TAVI group. In-hospital adverse clinical outcomes were assessed in each group. RESULTS: Pre-TAVI work-up revealed significant CAD in 36% of 1030 patients eligible for inclusion in the study. The overall prevalence of in-hospital death, stroke, major or life-threatening bleeding, minor bleeding, major vascular complications, minor vascular complications, pacemaker implantation, and acute kidney injury was 2.7%, 2.4%, 2.8%, 3.6%, 3.9%, 7.5%, 12.5%, and 2.7%, respectively. Among the studied population, 55% were admitted to the cardiac care unit. No significant statistical difference was observed between groups. Discussion. CAD-TAVI population was not more likely to develop in-hospital adverse clinical outcomes post-TAVI procedure compared to others. Also, no significant difference regarding in-hospital death was observed. In parallel, performing PCI prior to TAVI did not increase the risk of in-hospital death and complications. The difference in terms of the distribution of antithrombotic regimen may explain the higher prevalence of bleeding events in the PCI-TAVI group. CONCLUSION: This study provides direct clinical relevance useful in daily practice. No negative impact has been attributed to the presence of a concomitant CAD and/or preoperative PCI on the TAVI hospitalization period.
format Online
Article
Text
id pubmed-8016584
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-80165842021-04-05 Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation Matta, Anthony G. Lhermusier, Thibault Parada, Francisco Campelo Bouisset, Frederic Canitrot, Ronan Nader, Vanessa Blanco, Stéphanie Elbaz, Meyer Roncalli, Jerome Carrié, Didier J Interv Cardiol Research Article INTRODUCTION: The prevalence of coronary artery disease (CAD) detected in preoperative work-up for transcatheter aortic valve implantation (TAVI) is high. Instead, the management of a concomitant CAD remains unclear. We evaluate the impact of CAD and percutaneous coronary intervention (PCI) on TAVI procedures. MATERIALS AND METHODS: A retrospective study was conducted on 1336 consecutive patients who underwent TAVI in Toulouse University Hospital, Rangueil, France. The studied population was divided into 2 groups: CAD-TAVI group and No CAD-TAVI group. Then, the CAD-TAVI group was segregated into 2 subgroups: PCI-TAVI group and No PCI-TAVI group. In-hospital adverse clinical outcomes were assessed in each group. RESULTS: Pre-TAVI work-up revealed significant CAD in 36% of 1030 patients eligible for inclusion in the study. The overall prevalence of in-hospital death, stroke, major or life-threatening bleeding, minor bleeding, major vascular complications, minor vascular complications, pacemaker implantation, and acute kidney injury was 2.7%, 2.4%, 2.8%, 3.6%, 3.9%, 7.5%, 12.5%, and 2.7%, respectively. Among the studied population, 55% were admitted to the cardiac care unit. No significant statistical difference was observed between groups. Discussion. CAD-TAVI population was not more likely to develop in-hospital adverse clinical outcomes post-TAVI procedure compared to others. Also, no significant difference regarding in-hospital death was observed. In parallel, performing PCI prior to TAVI did not increase the risk of in-hospital death and complications. The difference in terms of the distribution of antithrombotic regimen may explain the higher prevalence of bleeding events in the PCI-TAVI group. CONCLUSION: This study provides direct clinical relevance useful in daily practice. No negative impact has been attributed to the presence of a concomitant CAD and/or preoperative PCI on the TAVI hospitalization period. Hindawi 2021-03-24 /pmc/articles/PMC8016584/ /pubmed/33824628 http://dx.doi.org/10.1155/2021/6672400 Text en Copyright © 2021 Anthony G. Matta et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Matta, Anthony G.
Lhermusier, Thibault
Parada, Francisco Campelo
Bouisset, Frederic
Canitrot, Ronan
Nader, Vanessa
Blanco, Stéphanie
Elbaz, Meyer
Roncalli, Jerome
Carrié, Didier
Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
title Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
title_full Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
title_fullStr Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
title_full_unstemmed Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
title_short Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
title_sort impact of coronary artery disease and percutaneous coronary intervention on transcatheter aortic valve implantation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016584/
https://www.ncbi.nlm.nih.gov/pubmed/33824628
http://dx.doi.org/10.1155/2021/6672400
work_keys_str_mv AT mattaanthonyg impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT lhermusierthibault impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT paradafranciscocampelo impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT bouissetfrederic impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT canitrotronan impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT nadervanessa impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT blancostephanie impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT elbazmeyer impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT roncallijerome impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation
AT carriedidier impactofcoronaryarterydiseaseandpercutaneouscoronaryinterventionontranscatheteraorticvalveimplantation